A $3.2 billion deal from GSK, accused of causing cancer with its drug Zantac in the United States
While GSK agrees to pay $3.2 billion to end a series of cases alleging that its heartburn drug Zantac could ...
Tag: GSK
While GSK agrees to pay $3.2 billion to end a series of cases alleging that its heartburn drug Zantac could ...